New data from @YaleThoracic shows patients with #NSCLC receiving neoadjuvant immune checkpoint inhibitors plus chemotherapy (ICI-CT) have improved survival - with excellent survival in patients with major pathological response (MPR) vs. those without.
jtocrr.org/article/S2666-…
@SmilowCancer @GavittWoodard @Sokim_33 @yalepathology @JTOonline

.@MitchElliott18 and #breastcancer advocate, Adina Isenberg, discuss advancements in breast cancer treatment, including the role of personalized therapy and blood testing, and patient advocacy tonight at 7:30pm on #YaleCancerAnswers.
🎧Listen live @wnpr
💻Listen later y, @YouTube
@SmilowCancer @YaleBreast #bcsm

Join us for a #lungcancer conference for patients:
"Living with Lung Cancer: Progress, Partnership, and Hope”
📅 Wednesday, Nov. 4, at 5pm
📍Attend in-person or online via Zoom
🫁The program will feature presentations from many of our experts in thoracic oncology with talks n surgical options, cutting-edge therapies, clinical trials, and supportive care.
➡️RSVP: bit.ly/3UymFZz
@YaleCancer @YaleThoracic @YNHH #LCSM

Thank you to our #GrandRounds presenters,
@TranMDPhD and @ishizukalab for sharing their insights on #melanoma and #merkelcell carcinoma. Their talks are available on our
@YouTube channel: youtu.be/v-Nm4poxNoY?si…
@SmilowCancer @YaleIBIO

Exercise oncology is not just good for patients, it may be a smart investment. A team from Yale completed a cost-effectiveness analysis of the #CHALLENGEtrial + demonstrated the economic viability of reimbursing supervised exercise for patients with #coloncancer in the US.
ascopubs.org/doi/pdf/10.120…
@SmilowCancer @GeorgeGoshuaMD @JCOOP_ASCO @ammanuelstaye @ManrajSra @SatokoItoMDPhD

Last week, Drs. @maryam_lustberg and Mary Jane Minkin @YaleObGynRes joined colleagues at the 'Managing Menopause After Breast Cancer' program at the #OncoMenopause Consortium in San Diego.
@SmilowCancer @YaleBreast

Why are #NOTCH1 mutations common in normal esophageal tissue, but less frequent in esophageal cancer? New research from @JeffTownsend reveals that cancer-associated mutations can have different effects depending on when they arise and which other mutations are present. These stage-specific evolutionary dynamics could help identify when targeted interventions may be most effective.
medicine.yale.edu/cancer/publica…
@SmilowCancer @GenomeMedicine @OncoAlert @YaleSPH

.@maryam_lustberg presented on supportive and palliative care in a Scientific Congress Highlights 2 session this morning at #ESMO26.
cslide.ctimeetingtech.com/esmo2026/atten…
@myESMO @SmilowCancer @YaleBreast

Please join us for #GrandRounds today at 12pm as @TranMDPhD and @ishizukalab share presentations on #melanoma and #merkelcellcarcinoma.
Join us in-person at Smilow Auditorium or online via Zoom: bit.ly/4zW8SLh.
@SmilowCancer @YNHH

A new @cell_res highlight from @samirzaidi + @SawyersLabMSKCC explores how next-gen, patient-derived #cancer models are expanding the Cancer Dependency Map #DepMap, revealing new therapeutic opportunities while underscoring the importance of tumor context and model fidelity.
nature.com/articles/s4142…
@SmilowCancer @MSKCancerCenter

New study results from @Cecchini_OncMD show Telisotuzumab adizutecan + bevacizumab appeared to improve efficacy outcomes with a manageable safety profile in patients with advanced #colorectalcancer, and the regimen is currently being evaluated in a Phase III trial, AndroMETa-560. #ESMO26
annalsofoncology.org/article/S0923-…
@SmilowCancer @myESMO @YaleGICancers @OncoAlert @Annals_Oncology

Today at #ESMO26, @maryam_lustberg presents 'Review of the development of a new cryocompression medical device for the management of CIPN in chemotherapy settings' in an EONS Satellite Symposium. #Paxman
cslide.ctimeetingtech.com/esmo2026/atten…
@SmilowCancer @YaleBreast @myESMO

Monday morning at #ESMO26, @Annechiangmd presents data on ABBV-706 monotherapy showing promising clinical benefit in heavily pretreated R/R small cell lung cancer. #SCLC
cslide.ctimeetingtech.com/esmo2026/atten…
@myESMO @SmilowCancer @YaleThoracic

Breast Medical Oncologist, @maryam_lustberg, is tonight’s guest on #YaleCancerAnswers, where she and host @DrEricWiner discuss a range of topics for #BreastCancerAwarenessMonth: ➡️approaches to #breastcancer, new treatments, antibody drug conjugates (ADCs) and more.
🎧Listen @wnpr
💻Listen later: @ApplePodcasts | @Spotify | @YouTube

@SmilowCancer @YaleBreast

Honoring @sistersjourney and their mission to educate, prevent, diagnose and treat women of color in the fight against breast cancer! ♥️🌸🫖#bcsm @YaleBreast @YNHH @YaleCancer

Sunday morning at #ESMO26, @BraunMDPhD presents on vaccines during a special symposium on renal cell carcinoma. #RCC cslide.ctimeetingtech.com/esmo2026/atten…
@myESMO @SmilowCancer

Today at #ESMO26, @Cecchini_OncMD presents a rapid oral presentation on updated results of a combination therapy vs. SOC study in patients with 3L+ #colorectalcancer.
cslide.ctimeetingtech.com/esmo2026/atten…
@myESMO @SmilowCancer @YaleGICancers

.@sundar__raghav presents 'Challenges in biomarker testing' in an educational session Saturday morning at #ESMO26.
cslide.ctimeetingtech.com/esmo2026/atten…
@myESMO @SmilowCancer @YaleGICancers

We’re excited to join oncology colleagues from around the world at #ESMO26 to share knowledge, exchange ideas, and explore the future of cancer care. We’re proud of our faculty presenting their research and look forward to engaging with the latest advances in #cancerresearch, yESMO @SmilowCancer @YNHH